NCT02649101 Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT02645175 Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue Status TERMINATED Phase PHASE2
NCT02642458 Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients Status UNKNOWN Phase N/A
NCT02632045 Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT02626039 Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients Status COMPLETED Phase N/A
NCT02626013 Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece Status COMPLETED Phase N/A
NCT02624700 2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT02611310 A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC) Status TERMINATED Phase N/A
NCT02608216 [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02607215 Platinum Rechallenge in Patients With Platinum-sensitive mTNBC Status UNKNOWN Phase PHASE2
NCT02595762 A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase N/A
NCT02594371 Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT02592746 A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC Status UNKNOWN Phase PHASE2
NCT02581839 Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate Status COMPLETED Phase PHASE2
NCT02580448 CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) Status COMPLETED Phase PHASE1/PHASE2
NCT02580396 Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine Status COMPLETED Phase NA